Company Lookup
عربي
Download Demo
 

Market News

This Month News

This Month News

send to a friend by email

JPH records net income of $6.18 million at the end of 2017

2018-02-18

According to the financial statements of Jerusalem Pharmaceuticals JPH for the year 2017, Net profit after tax of the period reached 6,186,852 USD Compared with Net profit after tax 3,050,959 USD for 2016, a net increase in profit of 102.78%.Total assets of the company reached 59,710,745 USD compared with total assets of 52,970,017 USD at the end of year 2016, a net increase of 12.73%.Total liabilities of the company reached 10,272,289 USD compared with total liabilities of 12,709,989 USD at the end of year 2016, a net decrease of 19.17%. Net ownership equity of the company reached 49,438,456 USD (Including Non-Controlling Interests of 825,910 USD) compared with total owner equity of 40,260,028 USD (Including Non-Controlling Interests of 526,771 USD) at the end of year 2016, a net increase of 22.80%.

 


 

2020-06-04
The PEX records average PE of 19.3x and average P/BV of 1.11x

 

 

 
Sahem Trading & Investments Company - PEX Member and licensed by PCMA
© All Rights Reserved 2013